RECITALSConsulting Agreement • August 14th, 2003 • Cancervax Corp • California
EXHIBIT 10.32 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. LICENSE...License Agreement • October 24th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • California
RECITALSLease • January 20th, 2005 • Cancervax Corp • Biological products, (no disgnostic substances)
RECITALSIndemnification Agreement • September 16th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • Delaware
AND SERONO B.V.Stock Purchase Agreement • December 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
RECITALSEmployment Agreement • August 14th, 2003 • Cancervax Corp • California
EXHIBIT 10.43 January 22, 2002 Mr. Gary Grubbs John Wayne Cancer Institute 2200 Santa Monica Boulevard Santa Monica, CA 90404 Re: Master Services Agreement between CancerVax Corporation ("CancerVax"), the John Wayne Cancer Institute ("JWCI") and...Letter Agreement • September 16th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.4 CANCERVAX CORPORATION AMENDED AND RESTATED 2003 EQUITY INCENTIVE AWARD PLAN STOCK OPTION AGREEMENT THIS AGREEMENT, dated as of the Grant Date set forth on Exhibit A hereto, (the terms of which are hereby incorporated by reference and made...Stock Option Agreement • May 6th, 2005 • Cancervax Corp • Biological products, (no disgnostic substances) • California
RECITALSEmployment Agreement • August 14th, 2003 • Cancervax Corp • California
PERFORMANCE-BASED VESTING CANCERVAX CORPORATION AMENDED AND RESTATED 2003 EQUITY INCENTIVE AWARD PLAN STOCK OPTION AGREEMENT THIS AGREEMENT, dated as of the Grant Date set forth on Exhibit A hereto, (the terms of which are hereby incorporated by...Stock Option Agreement • May 6th, 2005 • Cancervax Corp • Biological products, (no disgnostic substances) • California
PERFORMANCE-BASED VESTING CANCERVAX CORPORATION AMENDED AND RESTATED 2003 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE AND RESTRICTED STOCK AWARD AGREEMENT CancerVax Corporation (the "COMPANY"), pursuant to its Amended and Restated...Restricted Stock Award Agreement • May 6th, 2005 • Cancervax Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.30 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. LICENSE...License Agreement • October 24th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • California
EXHIBIT 10.3 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "Agreement") is entered into by and between CancerVax Corporation, a Delaware corporation (the "Company"), and _________ ("Executive"), and...Employment Agreement • November 15th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
RECITALSInvestors' Rights Agreement • December 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
by and amongMerger Agreement • August 14th, 2003 • Cancervax Corp • California
EXHIBIT 10.1 FORM OF [AMENDED AND RESTATED] EMPLOYMENT AGREEMENT THIS [AMENDED AND RESTATED] EMPLOYMENT AGREEMENT (this "Agreement") is entered into by and between CancerVax Corporation, a Delaware corporation (the "Company"), and _________...Employment Agreement • August 8th, 2005 • Cancervax Corp • Biological products, (no disgnostic substances) • California
MICROMET, INC. and ________, AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [__], 20___Preferred Stock Warrant Agreement • October 16th, 2009 • Micromet, Inc. • Biological products, (no disgnostic substances) • New York
Preferred Stock Warrant Agreement (this “Agreement”), dated as of between Micromet, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
MICROMET, INC. and ________, AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [__], 20___Common Stock Warrant Agreement • October 16th, 2009 • Micromet, Inc. • Biological products, (no disgnostic substances) • New York
Common Stock Warrant Agreement (this “Agreement”), dated as of between Micromet, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
andRights Agreement • November 8th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • New York
MICROMET, INC. and ________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [__], 20___Warrant Agreement • June 19th, 2009 • Micromet, Inc. • Biological products, (no disgnostic substances) • New York
Debt Securities Warrant Agreement (this “Agreement”), dated as of between Micromet, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
COMMON STOCKUnderwriting Agreement • September 16th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • New York
BY AND BETWEENLicense Agreement • October 24th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • California
EXHIBIT 10.2 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this "Agreement") is entered into by and between CancerVax Corporation, a Delaware corporation (the "Company"), and David F. Hale ("Executive"), and...Employment Agreement • November 15th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
Exhibit 10.42 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. MASTER SERVICES...Master Services Agreement • September 16th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • California
ARTICLE 1 DEFINITIONSCollaboration Agreement • October 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
AND CANCERVAX CORPORATION, A DELAWARE CORPORATIONLicense Agreement • August 14th, 2003 • Cancervax Corp • California
AGREEMENTTransfer Agreement • October 24th, 2003 • Cancervax Corp • Biological products, (no disgnostic substances) • California
RECITALSLease Agreement • December 29th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.1 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. SUBLICENSE AGREEMENTSublicense Agreement • March 15th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • Delaware
MICROMET, INC. Common Stock PURCHASE AGREEMENTPurchase Agreement • July 30th, 2009 • Micromet, Inc. • Biological products, (no disgnostic substances) • New York
Micromet, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom Piper Jaffray & Co. is acting as representative (the “Representative”), an aggregate of 14,000,000 shares (the “Firm Shares”) of Common Stock, $0.00004 par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 2,100,000 additional shares of Common Stock on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Agreement are herein collectively called the “Securities.”
MICROMET, INC. and ________, AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [__], 20___Debt Securities Warrant Agreement • October 16th, 2009 • Micromet, Inc. • Biological products, (no disgnostic substances) • New York
Debt Securities Warrant Agreement (this “Agreement”), dated as of between Micromet, Inc., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
RECITALSEmployment Agreement • March 29th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • California
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 21st, 2007 • Micromet, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 19, 2007, between Micromet, Inc., a Delaware corporation (the “Company”) and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
ANDCollaboration and License Agreement • December 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • New York
BETWEEN SILICON VALLEY BANK AND CANCERVAX CORPORATIONLoan and Security Agreement • December 29th, 2004 • Cancervax Corp • Biological products, (no disgnostic substances)
